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Abstract 
 
Surface plasmon resonance (SPR) based biosensors generate real-time binding data and is 
therefore well suited to analyse binding kinetics of two interacting molecules as well as for 
concentration measurements. Folate-binding protein (FBP) is present in, among others, milk 
and may affect intestinal absorption of folate. The objectives of this work were to 
investigate both the occurrence of bovine FBP in milk and FBP ligand binding properties 
using the SPR technique.  
 
In order to understand and predict the impact of FBP on folate stability and absorption of 
native or added folates (fortification) an SPR assay that detects both the free (unliganded) 
and total FBP content in milk was developed. The assay showed good compliance with an 
existing ELISA method that measures the total FBP content. It was shown that approx. 50% 
of the total FBP content in milk is not bound to folate. The SPR assay was further used for 
screening of the occurrence of free and total FBP in milk from Swedish diary cattle. A large 
variation in FBP levels among cows was observed. 
 
The binding kinetics between FBP and pure stereoisormeric forms of various folate 
derivatives were investigated. The results demonstrated that the interactions between FBP 
and the major forms of folate derivatives differ considerably. Each of the binding responses 
shown was well described by a 1:1 interaction model. The two folate forms that do not 
occur in nature, that is, folic acid and [6R]-5-CH3H4folate, had the highest affinity for FBP, 
20 and 160 pmol/L, respectively.  
 
The influence of different folate derivatives on the denaturation temperature of FBP and 
effect of pasteurization and UHT treatment on FBP binding to folate were studied. The 
binding of folate increased the denaturation temperature of FBP. The ability of FPB to bind 
folate was eliminated by UHT treatment but not by pasteurization, regardless of folate form 
bound.  
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Background 
Folate  
Nomenclature and chemical structure 
Folate is the generic term for all B-vitamins that exhibit vitamin activity similar to 
that of folic acid i.e. pteroyl-L-glutamic acid (PteGlu). The various compounds of 
this class are designated as “folates”. Folic acid is the most oxidised and most 
stable form of folate, and consists of an aromatic pteridine ring attached to para-
aminobenzoic acid, which in turn, is linked to one L-glutamic acid residue (Figure 
1). Folic acid occurs rarely in nature, but it is the synthetic form used for vitamin 
supplementation and food fortification because of its stability and low cost.     
 
 
Figure 1. Chemical structure of PteGlu. 
  
 
Folate in body tissues and foods are mainly 5,6,7,8-tetrahydro-
pteroylpolyglutamates, which contain a fully-reduced pteridine ring together with 
additional glutamic acid molecules linked by γ-peptide bounds. Reduced folate 
can exist with or without one-carbon substituent at the N
5, e.g. 5-methyl, 5-formyl, 
5-formimino or N
10, e.g. 10-formyl, positions, or have a single C bridge spanning 
these positions, e.g. 5,10-methylene, 5,10-methenyl (Figure 2c). The pteridine 
ring can also be partially reduced and exists with or without a one-carbon 
substituent at the N
5 or N
10 as shown in Figure 2a and 2b. Thus, there are many 
different derivatives of folic acid exhibiting the common vitamin activity as folate. 
The vitamin activity of these folates is expressed as long as the essential subunit 
structure of folic acid remains largely intact. In fact, the number of derivatives is 
further increased, as all fully reduced folate has two chiral centres: the α-C atom in 
the glutamic acid moiety and the C-atom in position 6 of the pteroyl moiety 
(Figure 2c). Consequently four possible diastereoisomers exist: [6S, αS], [6S, 
αR], [6R, αS] and [6R, αR]. The naturally occurring diastereoisomer of 
tetrahydrofolate (H4folate), 5-methyltetrahydrofolate (5-CH3-H4folate) and 5- 
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c) Fully reduced pteridine ring    
Substituent 
(R1) 
Substituent 
(R2)  Folate derivative       
-H -H  Tetrahydrofolate  (H4folate)    
-CH3 -H  5-methyltetrahydrofolate  (5-CH3-H4folate) 
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-H -HCO  10-formyltetrahydrofolate  (10-HCO-H4folate) 
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Figure 2 a-c. Structures and nomenclature of some folate derivatives with partially 
oxidised and fully reduced pteridine ring. The number of glutamate units (n) linked by a γ-
peptide bound varies from 0 to 7. 
b) 
*=tetrahedral stereocentres 
c)   9 
formyltetrahydrofolate (5-HCO-H4folate) are the [6S, αS]-diastereoisomers, 
whereas the natural diastereoisomers of 10-formyltetrahydrofolate (10-HCO-
H4folate), 5,10-methylenetetrahydrofolate (5,10-CH2-H4folate) and 5,10-
methenyltetrahydrofolate (5,10-CH
+=H4folate) are the [6R, αS]-diastereoisomers. 
It should be emphasized that [6R] configurations of the natural 10-substituted and 
5,10-bridged compounds are not inverse compared to tetrahydofolate, but 
according to Cahn-Ingold-Prelog (CIP) nomenclature rules the configuration is 
[6R]. Therefore, to avoid confusion about the stereochemistry, it has been agreed 
that all natural diastereoisomers of reduced folate should be defined as L-
diastereoisomers and all unnatural ones as D-diastereoisomers (Groehn & Moser, 
1999). 
 
Biological function  
Folate is essential for a wide range of biochemical pathways involving one-carbon 
transfer. In particular, folate plays an essential role in cell replication because they 
are required for synthesis of purines and pyrimindines, the nucleotides base pairs 
of DNA and RNA. The remethylation of homocysteine to methionine closely 
involves the metabolism of folate and other B-vitamins. Growth and pregnancies 
show increased demands for folate, deficiency can lead to impaired cell replication 
and accumulation of harmful metabolites, such as homocysteine. Impaired cell 
replication is first observed in fast replicating tissues such as the erythrocytes, 
causing megaloblastic anaemia (Wickramasinghe, 2006). An elevated plasma 
homocysteine level caused by a marginal folate intake is a risk factor for vascular 
disease (Boushey et al, 1995). Furthermore, a marketed protection against neural-
tube defects in foetus has been shown in women supplemented with folic acid 
before conception (MRC Vitamin Study Research Group, 1991; Czeizel & Dudas, 
1992).  
 
Bioavailability and absorption 
Folate bioavailability refers to the portion of ingested folate that is absorbed and 
becomes available for metabolic processes or storage. The folate bioavailability is 
dependent on a number of factors, including intestinal deconjugation of 
polyglutamyl folate, the food matrix, the instability of certain labile folate during 
digestion (or before ingestion), and the presence of certain dietary constituents that 
may enhance folate stability during digestion e.g. folate-binding protein and 
ascorbate (reviewed by McNulty & Pentieva, 2004).  
 
The absorption of folates occurs mainly in the proximal small intestine (jejunum). 
Before absorption across the mucosa can take place, dietary folates, which exist 
predominantly as polyglutamates, need to be hydrolysed to folate monoglutamate 
by the brush-border γ-glutamyl hydrolase, also called folylpolyglutamate 
carboxypeptidase or folate conjugase (Halsted, 1980). Many foods contain 
inhibitors of the intestinal brush-border folate conjugase enzyme and/or folate 
transport system (Tamura & Stokstad, 1973; Babu & Srikantia, 1976; Tamura et 
al., 1976). After cleavage to folate monoglutamates, the folate is absorbed by a 
carrier-mediated process at physiological concentrations, and by passive diffusion 
at higher concentrations (Selhub et al., 1984). Absorbed folate monglutamtes are   10
converted to 5-CH3-H4folate during the transit through the intestinal mucosa 
before being released into the portal vein. Synthetic folic acid is reduced and 
methylated partly in the intestinal mucosa and partly in the liver (reviewed by 
Steinberg, 1984). As a consequence of chemical instability of the naturally 
occurring folate and food mediated inhibition of the enzymes and proteins 
involved in absorption the bioavailability of folate varies considerably (Gregory, 
1997). 
 
Intake and dietary sources 
In Sweden, the recommended daily intake (RDI) of folate is 300µg for adults, 400 
µg for fertile women, and 500µg for pregnant and lactating women (Becker et al., 
2004). Most people in Sweden except for vegetarians and vegans, do not reach the 
RDI of folate (Livsmedelsverket, 2002). An inadequate folate intake occurs not 
only in Sweden but worldwide. Therefore, several countries have introduced folic 
acid fortification, e.g. USA (1998), Canada (1998), Chile (2000). Sweden and 
many other EU countries are currently discussing whether a mandatory folic acid 
fortification should be introduced but have not taken any decision so far except for 
Ireland. 
     
The main dietary sources of folate are foods of plant origin, i.e. vegetables, fruits, 
berries, fruit juices, cereals and potatoes, contributing 60% of the total intake. 
Meat, fish and egg products contribute 16% and dairy products contribute an 
additional 16% of the total intake of folate (Livsmedelsverket, 2002).  
 
 
Folate binding protein 
The family of folate binding proteins 
Absorption and cellular uptake of folate is mediated by two different classes of 
membrane proteins. One class consists of the reduced folate carrier (RFCs), which 
are transmembrane proteins that bind reduced folate with a micromolar affinity. 
The other class is the family of folate-binding protein (FBP or Folbp), also known 
as the folate receptor (FR). Human FR is encoded by a family of genes whose 
homologous products are termed FR –α, –β and –γ (Lacey et al., 1989; Sadasivan 
& Rothenberg, 1989; Elwood, 1989; Ratnam et al., 1989; Shen et al., 1994; Shen 
et al., 1995). FR–α and –β are attached to the cell membrane by a glycosyl-
phosphatidylinositol (GPI) anchor; FR–γ is constitutively secreted because it lacks 
a signal for GPI modification (Shen et.al, 1995). The membrane associated forms 
of FBP are capable of transporting folate into the cell. However, other folate 
uptake pathways are generally used by adult tissues (Matherly & Goldman, 2003) 
and the functions of these membrane-bound FRs are not clear in most tissues. The 
most commonly expressed receptor isoform, i.e. FR-α, in normal tissues occurs 
largely at the apical/luminal surface of epithelial cells where it is not supplied with 
folate from blood circulation. In proximal kidney tubules, FR mediates 
reabsorption of folate from urine due to the expression of FR on the apical/luminal 
or urine-facing surface of the tubule cells (Weitman et al., 1992). Gene knockout 
studies have shown that FR-α is essential for nerve tube development in the   11 
embryo but folate supplementation allows normal development (Piedrahita et al., 
1999). Knockout of the FR-β gene in mice is associated with an apparently normal 
phenotype but may increase the risk of arsenic-induced neural tube defects, 
especially when dietary folate is restricted (Wlodarczyk et al., 2001).  
 
The origin of soluble folate-binding protein (sFBP) is either from FR–γ, because it 
is constantly secreted, or from the membrane bound forms. sFBP from FR-α in 
human malignant tissue culture (KB) and placental cells has been demonstrated to 
result from both phosholipase cleavage of the GPI anchor and from proteolysis by 
an Mg
2+-dependent protease (Luhrs & Slomiany, 1989; Antony et al., 1989; 
Elwood, Deutsch & Kolhouse et al., 1991; Yang et al., 1996). FR–β is processed 
intracellularly by two independent pathways, one resulting in GPI anchor addition 
and another resulting in its secretion (Wang et al., 1997).  
 
 
Soluble bovine folate binding protein in milk 
In 1967 Ghitis reported the presence in bovine milk of a heat labile 
macromolecular factor that protected milk folate against adsorption to activated 
charcoal. This observation led to the conclusion that bovine milk contains high 
affinity folate binding protein (FBP) (Ghitis, 1967). Since then the protein has 
been extensively studied and well characterized. FBP isolated from bovine milk 
contains 222 amino acids. The polypeptide contains 8 disulphide bridges and the 
molecular weight of the protein part is 25,700 Da (Svendsen et.al., 1984). The 
protein is highly glycosylated with 2 potential sites for N-linked glycosylation. 
The final molecular weight is about 30,000-35,000 Da (Salter et.al., 1981; 
Svendsen et.al., 1984). Recently, a 19 amino acid long signal sequence of bovine 
milk FBP was sequenced (Smith et al., 2005). The signal sequence is cleaved off 
before secretion into the milk. At saturation FBP binds approx. 1 mol of folate/mol 
of protein at pH 7.2 (Salter et al, 1981). The folate-binding capacity of FBP varies 
with pH. 5-methyltetrahydrofolate is totally dissociated at pH below 5 and folic 
acid at pH slightly above 3 (Salter et al, 1981).  
 
FBP have been isolated by different affinity chromatographic methods (Salter et 
al., 1972; Treloar, Grieve & Nixon, 2000) sometimes in combination with ion-
exchange chromatography (Svenden et al., 1979). The occurrence of FBP in 
bovine milk is in the range of 5-8mg/L (170-250 nmol/L) (Salter et al., 1972; 
Wigertz, Svensson & Jägerstad, 1997). There are conflicting results in the 
literature on how pasteurization affects the FBP content in milk. Wigertz et al 
(1996) found 20% reduction as measured by ELISA, Ford (1974) found 10% 
reduction of the folate-binding capacity and Kohashi et al (1985) observed an 
almost complete reduction of the folate-binding capacity after pasteurization. 
Further, Wigertz et al (1996) found more than 95% reduction of the FBP content 
after UHT treatment. Conflicting results from these studies could be caused by the 
fact that common pasteurization temperatures are very close to those at which 
denaturation of FBP takes place.  Gregory (1982), using gel filtration analysis, 
found an increased molecular mass after heat treatment and suggested an heat-  12
induced alternation of FBP as an explanation for the changed structural and 
functional characteristics of FBP in processed milk products (Gregory, 1982). 
The proposed function of FBP in milk is to sequester folate from blood to secure 
an adequate supply to the neonate (reviewed by Parodi, 1997). Studies have also 
shown that FBP enhances folate stability under various conditions (Jones & 
Nixon, 2002). Earlier, FBP was regarded as a stimulant of folate absorption in 
human (Colman et al., 1981; Salter et al., 1988) but more recent studies have 
indicated that FBP forms complex with folate, especially with folic acid, resulting 
in lower folate bioavailability (Arkbåge et al, 2003; Verwei et al, 2004; Witthöft et 
al, 2006).   
 
Sequence homology 
Figure 3 compares the amino acid sequence of bovine milk FBP (Smith et al., 
2005), human FR-α (Elwood, 1989), and chicken riboflavin-binding protein 
(RfBP) (Zheng et al., 1988a).  Amino acids indicated with a star are identical in all 
sequences in the alignment. The sequence alignment shows that all tryptophan 
residues in RfBP are conserved in FBP and all 16 cystine residues present in FBP 
are conserved in RfBP. In the region from residue 36 to 211, where the sequences 
clearly correspond, the sequence identity is 30%. This indicates a structural and 
functional similarity of RfBP and FBP (Zhen et al., 1988b; Monaco, 1997). The 
sequence identity between FBP and human FR-α is 77%. The crystal structure of 
RfBP has been determined (Monaco, 1997) and shows that all the conserved 
cystine residues are present in the ligand-binding domain. The structure also 
shows that five out of six tryptophans present in the protein molecule are clustered 
in the neighbourhood of the ligand-binding site. The plane formed by the 
tryptophans is in direct contact with the plane of the ligand. Folate and flavins are 
functionally distinct but they do share structural resemblance because both are 
hydrophobic aromatic ring systems. It is therefore plausible that an ancestral 
protein had the capacity to bind both the vitamins and that a few amino acids 
replacements could modify the binding specificities (Zhen et al., 1988b).  
 
Affinity and aggregation 
Attempts to describe the affinity of the interaction between folate and FBP have 
been inconclusive since previously reported equilibrium dissociation constants 
(KD) at neutral pH have exhibited a dependence on the concentration of FBP used 
for their determination (Hansen, Holm & Lyngbye et al., 1978; Salter et al., 1981; 
Hansen et al., 1983).  In 2004, Nixon, Jones & Winzor interpreted their own and 
published data and estimated KD theoretically for the interaction between folic 
acid and FBP to 20 pM (or even lower). However, no one has confirmed it 
experimentally so far. The strength and binding kinetics of receptor-folate 
interactions are essential to elucidate for understanding of folate bioavailability 
and folate metabolism. Further, this knowledge is important because some 
methods used for folate analysis, e.g. radio protein binding assay (RPBA), and 
affinity columns used for folate extraction or enrichment are based on FBP-folate 
interactions. Variations in both response and recovery have been observed   13 
(Strålsjö et al, 2002; Konings, 1999) and those variations are most likely caused 
by differences in binding kinetics between the different folate derivatives.  
 
 
Bovine milk FBP  MAWQMT-QLLLLALVAAAWGAQAPRTPRARTDLLNVCMDAKHHKAEPGPE 49
Human FR-α  MAQRMTTQLLLLLVWVAVVGEAQTRIAWARTELLNVCMNAKHHKEKPGPE 50 
Chicken RfBP  --------MLRFAITLFAVITSSTCQQYG-------CLEGDTHKANPSPE 35 
                               :* : :   .     .    .       *::.. ** :*.** 
 
Bovine milk FBP  DSLHEQCSPWRKNACCSVN-TSIEAHKDISYLYRFNWDHCGKMEPACKRH 98 
Human FR-α  DKLHEQCRPWRKNACCSTN-TSQEAHKDVSYLYRFNWNHCGEMAPACKRH 99 
Chicken RfBP  PNMHE-CTLYSESSCCYANFTEQLAHSPIIKVSNSYWNRCGQLSKSCEDF 84 
                        .:** *  : :.:** .* *.  **. :  : .  *::**::  :*: . 
 
Bovine milk FBP  FIQDTCLYECSPNLGPWIREVNQRWRKERVLGVPLCKEDCQSWWEDCRTS 148 
Human FR-α  FIQDTCLYECSPNLGPWIQQVDQSWRKERVLNVPLCKEDCEQWWEDCRTS 149 
Chicken RfBP  TKKIECFYRCSPHAARWIDPR----YTAAIQSVPLCQSFCDDWYEACKDD 130 
                        :  *:*.***: . **        .  : .****:. *:.*:* *: . 
 
Bovine milk FBP  YTCKSNWHKGWNWT-SGYNQCPVKAAHCRFDFYFPTPAALCNEIWSHSYK 197 
Human FR-α  YTCKSNWHKGWNWT-SGFNKCAVGAACQPFHFYFPTPTVLCNEIWTHSYK 198 
Chicken RfBP  SICAHNWLTDWERDESGENHCKS--KCVPYSEMYANGTDMCQSMWGESFK 178 
                         *  ** ..*:   ** *:*        :   :.. : :*:.:* .*:* 
 
Bovine milk FBP  VSNYSRGSGRCIQMWFDPFQGNPNEEVARFYAENPTSGSTPQGI------ 241 
Human FR-α  VSNYSRGSGRCIQMWFDPAQGNPNEEVARFYAA-AMSGAGPWAAWPFLLS 247 
Chicken RfBP  VS---ESSCLCLQMNKKDMVAIKHLLSESSEESSSMSSSEEHACQKKLLK 225 
                       **   ..*  *:**  .   .  :          . *.:   .        
 
Bovine milk FBP  ------------- 
Human FR-α  LALMLLWLLS--- 257 
Chicken RfBP  FEALQQEEGEERR 238 
   
 
Figure 2. Alignment of amino acid sequences. From top; bovine milk FBP (Smith 
et al., 2005), human FR-α (Elwood, 1989), and chicken RfBP (Zheng et al., 
1988a).  Positions that have identical amino acids are marked with a star; two dots 
means that conserved substitution have been observed; one dot means that semi-
conserved substitutions are observed. Sequence alignment was preformed in 
clustralw 1.83 (http://www.ebi.ac.uk/clustalw/).  
 
 
Aggregation of proteins into insoluble complexes is a common phenomenon in 
biology. Protein aggregation is widely viewed as a non-specific coagulation of 
incompletely folded or partially denatured polypeptides, driven by the interaction 
among inappropriately exposed hydrophobic surfaces. However, refolding studies 
of chemically denatured polypeptides suggest that protein aggregation in vitro is 
due to specific intermolecular interactions among defined domains within 
structured folding intermediates (Wetzel, 1996). Evidence of this specificity is 
found in seeding behaviour of amyloidogenic proteins (Jarrett & Lansbury, 1992) 
and in the selectivity of aggregate formation by model proteins (Speed, Wang & 
King, 1996). Even though the exact nature of the FBP aggregates is not known, 
the aggregation shows a concentration-dependent aggregation enhanced upon 
addition of folate (Pedersen et al., 1980; Hansen et al., 1983). It has further been 
observed that liganded (holo) FBP forms hydrophilic water-soluble polymers, 
whereas unliganded (apo) FBP aggregates have a hydrophobic character (Holm, 
Hansen & Hoier-Madsen, 2001). Hansen and Holm have suggested that ligand 
binding is associated with a conformational change that increases the affinity to 
the ligand and increases FBP aggregation (Holm, Hansen & Hoier-Madsen, 2001; 
Holm & Hansen, 2001; Christensen, Holm & Hansen, 2006). This hypothesis is 
strongly questioned in this thesis (Paper IV).    14
Measurements 
Traditionally the only direct technique used for determination of FBP has been 
enzyme-linked immunosorbent assay (ELISA) (Hoier-Madsen, Hansen & Holm,  
1986). Before the development of the ELISA, FBP was quantified indirectly by 
measuring the folate content after absorption to charcoal of excessive unbound 
folate. The ELISA is based on the recognition of FBP by a polyclonal antibody 
raised against bovine milk FBP. The method does not distinguish between whether 
FBP are complexed with folate or not. In recent years there has been an increased 
demand for an assay that can distinguish the free apo-form from the complexed 
holo-form of the protein. The surface plasmon resonance (SPR) assay described in 
this thesis (Paper I) fulfils those demands. In 2004 another SPR method was 
developed by Indyk & Filonzi (2004) this method has an easier analytical scheme 
and measures only the apo-form. 
 
 
 
Table 1. Commercial optical biosensor technologies 
 
 
 
 
 
Manufacturer                               
 
Platforms 
Number of 
publications in 
2005 
Biacore AB  Biacore, Bialite, J, Q, X, 
1000, 2000. 3000, Flexchip, 
S51 
882 
Affinity Sensor  IAsys, IAsys+, IAsys Auto  40 
Texsas Instrument  Spreeta  20 
EcoChemie Autilab  Espirit  10 
Optrel Multiskop  10 
GWC Technologies  SPRimager II  8 
Nippon Laser & Electronics  SPR-670  8 
Windsor Scientific  IBIS, IBIS-II  8 
Resonant Probes  SPRTM  6 
Corning Epic  4 
Toyobo MultiSPRinter  4 
Analytical µ-system  BIOSUPLAR, 
BIOSUPLAR-2 
3 
Reichert Analytical 
Instruments 
SR7000 3 
DKK Corp.  SPR-20  2 
Genoptics SPRi-Array  2 
Artificial Sensing  OWLS  1 
Johnson & Johnson Clinical 
Diagnostics 
Unnamed 1 
Vir Biosensor  VirChip  1   15 
Biosensors  
A biosensor is a device that uses label-free techniques to detect biologically active 
molecules. Typically, the detector molecule must be connected to a sensor that can 
provide real-time monitoring. Biosensors based on biological materials are now 
used in a wide variety of disciplines, including medicine, food industry and 
environmental science. After the development more than a decade ago (Jönsson et 
al., 1991) of the first biosensor based on the surface plasmon resonance (SPR), the 
use of this technique has increased steadily. Although there are several SPR-based 
systems, the most widely used one is the BIAcore (GE Healthcare, Uppsala, 
Sweden). All commercially available SPR systems found on the market in 2005 
(reviewed by Rich & Myszka, 2006) are shown in Table 1, including the numbers 
of publications for each system. As seen in Table 1, Biacore totally dominates the 
use with more than 800 published articles in 2005. 
 
 
Analysis with Biacore equipment 
The main components of the Biacore system are the interchangeable sensor chip, 
the microfluidic sample handling system and the SPR detector. Aqueous samples 
are injected over the sensor chip surface immobilised with one of the interacting 
partners. Binding of the interactant is detected and quantified in real-time by the 
surface sensitive detector. The interactant free in solution is referred as the analyte. 
 
Optical system 
The underlying physical principles of SPR are complex and a detailed theoretical 
understanding of the event is not necessary for an adequate working knowledge of 
the technique. In brief, SPR-based instruments use an optical method to measure 
the refractive index near (within approx. 300 nm) a sensor surface. In order to 
detect an interaction, one molecule is immobilised onto the sensor surface. The 
binding partner (the analyte) is injected in aqueous solution (sample buffer) 
through the flow cell under continuous flow. When the analyte binds to the 
immobilised molecule on the sensor surface, the mass at the surface increase, and 
thereby the refractive index (Figure 4). This change in refractive index is 
measured in real time, and plotted as response or resonance units (RU) versus time 
(a sensorgram). One RU represents the binding of approximately 1 pg 
protein/mm
2.  
 
The sensorgram provides essentially two kinds of information: (1) the rate of 
interaction (association, dissociation or both), which provides information on 
kinetic rate constants and analyte concentration; and (2) the binding level which 
can provide information on affinity constants and analyte concentration. 
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 Figure 4. Surface plasmon resonance (SPR) biosensor principle. The binding of 
biomolecules to the sensor surface increase the refractive index, which induces 
shift of the SPR angle. The shift is directly proportional to the mass increase.  
 
 
Sensor surface 
The sensor chip consists of a gold-coated glass slide embedded in a plastic support 
platform. The gold film is covered with a coupling matrix e.g. carboxymethylated 
dextran via a linker layer. Different types of sensor surfaces are available, but the 
most frequently used surface is carboxymethylated dextran, CM5 (Baird & 
Myszka, 2001). The coupling matrix is important for the characteristics of the 
surface. By using a coupling matrix the immobilisation capacity of molecules are 
enhanced. Furthermore, the ligand will be easier accessed by the interacting 
molecule, and the hydrophilic structure of the matrix minimises non-specific 
adsorption of proteins (Johnson, Löfås & Lindquist, 1991; Jönsson et al., 1991).  
 
Flow system 
When a sensor chip is docked in the instrument, the integrated micro-fluidic 
cartridge (IFC) is pressed against the chip surface. Four flow cells are thereby 
formed; the volume of the flow cells varies between instrument models. The 
opposite side of the sensor chip, i.e. the glass side, is pressed against a glass prism 
in the optical unit. The IFC, together with an autosampler, controls the continuous 
flow of buffer or sample over the sensor surface via a number of loops. For 
Biacore 1000 and Biacore Q only one flow cell can be monitored at the time. In 
newer instrument used for kinetic interaction analysis (i.e. from Biacore 2000) a 
sample can pass over four flow cells in sequence and the response for all the flow 
cells can be monitored in parallel.  
 
 
Concentration analysis 
The Biacore instrument can be used for concentration determination of both large 
and small molecules. Since the assays are based on specific binding between two 
interaction partners, the values obtained reflect the concentration of analyte which   17 
is active with respect to this binding. There are different approaches to measuring 
concentration. One is to measure the amount of analyte bound at a fixed time after 
sample injection has finished. It is also possible to measure the rate of analyte 
binding at the beginning of sample injection. If the association is limited by mass 
transport, the binding rate is directly proportional to the analyte concentration and 
independent of association kinetics. Low molecular weight analytes, which do not 
give a measurable direct response, can be assayed by using competitive techniques 
i.e. when a competitive component is measured directly instead of the small 
analyte.  Competitive methods in solution can also be used for very large 
molecules and particles such as viruses (BIAtechnology Handbook, 1994). 
 
 
Kinetic analysis 
The advantage of measuring kinetics compared to affinity is that kinetics 
determines whether a particular complex forms or dissociates within a given time 
span. Affinity determines how much of the complex is formed at equilibrium, and 
the same affinity value can result from different combinations of association and 
dissociation rates. 
 
The fact that the Biacore® generates real-time binding data makes it well suited 
for analysis of binding kinetics. The monitored data can be analysed to give values 
for association and dissociation rate constants, and equilibrium constants. Figure 5 
shows schematically the interactions that occur at the sensor surface. The analyte 
(A) and the ligand (B) interact to form a complex (AB) and a response is 
generated. Typical ranges for rate constants measurable with Biacore® technology 
are: association constant (ka), 10
3-10
7 M
-1s
-1; and dissociation constant (kd), 10
-6-
10
-1 s
-1 (Kinetic and affinity analysis with Biacore, 2003). 
 
For collection of detailed kinetic data it is important to have a good experimental 
design, good data collection and data processing to avoid artifacts (Myszka, 1997; 
Morton & Myszka, 1998; Myszka, 1999; Myszka, 2000). 
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Figure 5. Overview of the basic interactions at the biosensor surface. The ligand 
(B) is attached to the surface via the flexible carboxymethylated dextran. During 
the association phase, analyte (A) is flowed past the surface. km is the mass 
transport coefficient used to describe the diffusion of analyte through the unstirred 
solvent layer. ka and kd are the rate constants, which describe the formation of the 
complex (AB).  
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Objectives 
The limited data up till now published in the literature on concentrations of FBP in 
raw and heat-processed cow milk are based on an enzyme-linked immunosorbent 
assay (ELISA) measures total FBP but does not discriminate between free FBP 
(apo) and folate bound (holo) FBP. In order to understand and predict the impact 
of FBP on folate stability and absorption of native or added folates (fortification), 
free and folate-bound FBP in milk should be determined. Moreover there is a lack 
of data on the interactions between different forms of folate and FBP in foods. 
This information is needed for the understanding of folate absorption and could 
also be useful in relation to other folate-binding proteins present in various 
mammal tissues. Furthermore, FBP is an important constituent in protein-binding 
methods used to quantify folate in clinical samples and foods. Since the principles 
behind these methods rely on the interaction between folate and FBP more data on 
binding kinetics are desirable to fill the gap of limited and inconsistent knowledge 
in this field. Almost all milk products on the market are pasteurized or UHT-
treated, but the effects of heat treatment on FBP concentration and FBP binding 
capacity are not clearly understood. An interesting question is whether the folate 
form affects the heat stability of FBP and whether it is possible to more exactly 
establish FBP’s heat denaturation temperature using differential scanning 
colorimetry (DSC). The SPR technique has a great potential to study protein-
vitamin interactions more specific than up till now used techniques. In the present 
thesis, an SPR assay is developed and validated for quantification of FBP in 
bovine milk. Moreover, the SPR-based assay is investigated as a suitable method 
for studying binding kinetics in model systems at ambient temperature and binding 
capacities of FBP after heat treatment of bovine milk.  
 
The specific objectives in the present work were: 
 
•  To develop and validate an SPR-based assay that could differentiate 
between liganded (holo) and unliganded (apo) form of FBP in bovine 
milk (Paper I). 
 
•  To screen for the amount of total FBP and apo-FBP in individual cow 
milk samples in relation to breed, lactation stage and lactation number. 
To investigate the relation between levels of FBP and total protein, fat 
content and cell count using SPR-based assay (Paper II). 
 
•  To investigate the binding kinetics of FBP and different folate derivates, 
and in addition, the effect of stereoselectivity on the FBP binding 
properties using SPR-based assay (Paper III). 
 
•  To investigate how different folate derivatives influence the denaturation 
temperature of FBP, and how the heat treatment, i.e. pasteurization and 
UHT treatment of FBP, affects FBP binding to folate using DSC and 
SPR-based assay, respectively.  (Paper V).   20
Methods 
Methods used in the present thesis are summarised below, for details see Paper I-
III and V. 
 
 
FBP Purification 
FBP used as standard and for Differential Scanning Calorimetry (DSC) was 
isolated from whey protein concentrate by affinity chromatography using EAH-
Sepharose 4B (GE Healthcare, Uppsala, Sweden). Folic acid was coupled via the 
free carboxyl group to the matrix. Then 50 g whey protein concentrate was 
dissolved in 5 L deionised water and the pH was lowered to 3 by addition of 5M 
HCl under agitation to dissociate bound folate from FBP. The sepharose gel was 
added to the whey protein concentrate solution and pH was increased to 7 by a 
slow addition of 5M NaOH. After 3 h agitation the gel was washed on a glass 
filter with deionized water until a clear eluate was obtained. The gel was then 
packed into a column and connected to Äkta
® FPLC system. The gel was further 
washed with 0.1 M phosphate buffer, pH 7.2, containing 0.5 M NaCl, until the UV 
absorbance (A280nm) of the eluate was negligible. The bound FBP was dissociated 
and eluated by 0.1 M acetate buffer, pH 3.5. The FBP containing fraction was 
collected, dialysed against milliQwater (Millipore, Bedford, MA, USA), freeze-
dried and stored at -70°C until further use. To determine the concentration of FBP, 
the A280nm of a 1mg/mL solution of FBP was used as published by Svendsen et.al. 
(1979). Purity of the isolated FBP was checked by SDS-PAGE using silver 
staining technique. Western blotting was further used to characterise the multiple 
bands that FBP gives due to different levels of glycosylation.   
 
 
Biacore assays 
Direct binding of FBP to either folate or FBP immobilized on the sensor surface 
was used for all assays. 
 
Immobilisation  
The pteridine ring on folate molecules exhibiting vitamin activity contains an 
amine group. This ring system is essential for the binding to FBP; therefore direct 
amine coupling to the activated dextran was not possible. Instead, folic acid and 
the other derivatives used were converted to their hydroxysuccinimidyl derivatives 
and coupled to amino groups on the sensor surface. FBP was immobilized directly 
to the sensor surface through amine coupling.  
 
Concentration analysis 
To facilitate measurements of the total FBP content in milk, endogenous folate 
was removed by a combination of low pH to dissociate the FBP-folate complex 
followed by a membrane molecular weight cut-off filtration (10kDa) (Millipore, 
Bedford, MA, USA). To make it possible to perform a cut-off filtration of milk,   21 
whey was prepared; the caseins in the milk would surely clog the filter when 
lowering pH. Whey, both for total and free FBP measurements, was diluted to a 
final dilution of 1:10 before injection. FBP used for calibration was diluted in 
running buffer (HBS-EP) pH 7.4 (10 mmol/L 4-[2-hydroxyethyl] piperazine-1-
ethane-sulfonic acid (HEPES), 3.0 mmol/L EDTA, 150 mmol/L NaCl, 0.005% 
(v/v) surfactant P-20) because of the presence of endogenous folate in milk. The 
range of the standard curve was set to a level covered the range of the diluted 
(1:10) normal milk samples. In order to minimize unspecific binding to the sensor 
surface, 0.1 M phosphate buffer, pH 7.4, containing 0.5 M NaCl was injected 
before change in response due to bound FBP was determined. Regeneration of the 
surface was performed by injection of 10 mM glycine buffer, pH 2.0. Calibration 
was performed both before and after measurements of a series of unknown 
samples to check the efficiency of the sensor chip regeneration between 
measurements. As a reference method an ELISA was used (Hoier-Madsen, 
Hansen & Holm, 1986). 
 
Kinetic measurements 
Concentration series of FBP were injected for collection of detailed kinetic data 
over different folate surfaces. The concentration of the concentration series and 
the length of time needed for dissociation was monitored and depended on the 
folate derivative. All binding experiments were carried out with HBS-EP running 
buffer, pH 7.4, at 25°C, and each concentration was injected in triplicate using 
random order. Data were processed and analysed by using double referencing 
(Myszka,1999). To obtain kinetic rate constants, adjusted response data were fitted 
with nonlinear least-squares regression analysis. Constants reported represent the 
average of three independent analyses of each FBP-folate interaction. 
 
FBP-FBP binding 
To investigate the influence of ligand on FBP aggregation apo-FBP was manually 
injected over an immobilized FBP surface that was either saturated with folic acid 
or not. The experiments were carried out with HBS-EP running buffer (pH 7.4) at 
25°C.  
 
 
Differential Scanning Calorimetry  
The thermal properties of FBP-ligand interaction were studied by DSC. The 
measurements were carried out on a DSC 6200 from Seiko Instruments Inc. 
(Shizuoka, Japan) over the temperature range of 6–140°C with a scanning rate of 
10°C min
−1. Folate-free freeze-dried FBP was diluted in 0.1 M phosphate buffer, 
pH 6.7, with and without the investigated folate derivative, to a final concentration 
of 0 or 1.5mg/mL folate and 10% (w/v) FBP. Transition enthalpy (ΔH expressed 
as J/g dry matter) and denaturation temperature (Td) were determined by 
EXSTAR6000 Thermal Analysis System on a Hewlett Packard computer.  
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Results and discussion 
I. Determination of folate-binding proteins from milk by optical 
biosensor analysis (Paper I) 
This paper describes an SPR-based method for detection of FBP in cow milk. The 
detection is based on the specific interaction between folic acid and FBP. The 
method measures both the total FBP content and the unliganded (apo) form of the 
protein. Consequently, the method was able to indirectly differentiate holo-FBP 
from apo-FBP which was not possible before with such high precision. The assay 
showed good compliance with an existing ELISA method. The repeatability (CV) 
of the biosensor assay was high, i.e. at an FBP concentration of 0.38µg/mL it was 
1.2-3.6% within-assay on 3 different days and 6.4% between days. Since the 
biosensor method is based on the specific interaction between FBP and PGA, 
endogenous folate must be removed before analysis of the total FBP content. This 
was achieved by a combination of low pH and molecular weight cut-off filtration. 
Further, it was demonstrated that the pteridine moiety of folate was essential for 
the interaction. In 2004 Indyk and Filonzi described another SPR-based assay for 
detection of FBP in cow milk. The analytical scheme of the described methods 
differed in several aspects. Most importantly, in Indyk and Filonzi’s method no 
sample pre-treatment stage was included since that method measures apo-FBP 
directly without removal of fat or caseins. The absence of pre-treatment is 
beneficial because this provides operational simplicity and avoidance of FBP 
losses. A weakness of such approach is that it is not possible to detect the total 
FBP concentration because of FBP binding to endogen folate in milk. The method 
published by Indyk and Filonzi showed approx. 50% higher levels of apo-FBP 
compared to those obtained by our method. However, apart from a divergent 
analytical scheme, different FBP standards were used because of absence of an 
accepted FBP reference material. Furthermore, different milk was used and as 
shown in Paper II, the FBP content in milk varies considerably among cows. The 
differences in FBP levels between those two methods might also be due to sample 
storage, which may affect the aggregation of protein as discussed in the 
methodological consideration below. Additionally, consumer milk was tested by 
Indyk and Filonzi (2004) and, as established in Paper V, heat-treatment, e.g. 
pasteurization, affects FBP through an increase in aggregation.   
  
 
II. Factors influencing levels of folate-binding protein in bovine 
milk (Paper II) 
In this work, the developed SPR assay (Paper I) was used for screening of the 
occurrence of FBP in milk. FBP levels of total and apo-form were determined in 
individual milk samples from 41 Swedish Red and White dairy cattle and from 25 
Swedish Friesian dairy cattle. To evaluate the influence of lactation stage on FBP 
levels, milk samples were also taken from 5 cows at 1, 3, 10, 30, 60 and 90 days 
post partum. The samples were stored at -80ºC and analysed within a few weeks. 
The results showed that there was a considerably variation between cows in levels 
of both total FBP content and apo-FBP, whereas the ratio between total FBP and   23 
its apo-form was relatively constant. The range for the total FBP content was 2.9-
11.1 µg/mL (91-347 nmol/L) and this agrees with the ELISA results of 170-210 
nmol/L reported by Wigertz et al (1997) measured in raw and pasteurized milk. 
The range for apo-FBP was 1.1-5.6 µg/mL (34-175 nmol/L). The results show that 
approx. 50% of the total FBP content is not bound to folate. The total protein 
content was positively to the amount of apo-FBP (r=0.30), and negatively 
correlated to the holo-form (r=-0.29). The level of FBP was increased at the 
beginning of lactation, which is in agreement with the results of Indyk and Filonzi 
(2004). No differences were found between the two investigated Swedish dairy 
breeds.  
 
 
III. Affinity and rate constants for interactions of bovine folate-
binding protein and folate derivatives determined by optical 
biosensor technology. Effect of stereoselectivity (Paper III) 
Paper III is the first study that has investigated binding kinetics between FBP and 
pure stereoisormeric forms of various folate based on real-time monitoring of 
association and dissociation rates quantified by SPR biosensor technology. The 
results demonstrate that there are marked differences in the interactions between 
FBP and the major forms of folate derivatives. Each of the binding responses was 
well described by a 1:1 interaction model. Considerable differences were found 
for both association rate constants (ka) and dissociation rate constants (kd) between 
the different folate forms. Folic acid exhibited the most rapid association rate 
constant and the slowest dissociation rate constant and thus had the highest 
affinity because the affinity are calculated by the quotient of kd/ka. [6S]-5-HCO 
H4folate had the most rapid dissociation rate constant and additionally the slowest 
association rate and thus the lowest affinity. The calculations of equilibrium 
dissociation constant (KD), showed that the two folate forms that do not occur in 
nature, i.e. folic acid and [6R]-5-CH3H4folate, had the highest affinity for FBP, 20 
and 160 pmol/L, respectively. Among the naturally occurring folates, [6S]-5-
H4folate had the highest affinity (250 pmol/L), [6S]-5-CH3H4folate almost 10-fold 
lower (2000 pmol/L) and [6S]-5-HCOH4folate the lowest affinity of all (12000 
pmol/L). 
 
In vitro and in vivo studies indicate that FBP in complex with folic acid results in 
lower folate bioavailability (Arkbåge et al, 2003; Verwei et al, 2004; Witthöft et 
al, 2006). Recent published data also show that kinetic behavior and distribution 
differ between folic acid and reduced folate in humans (Wright et al., 2005). It is 
likely that these differences are caused by different binding kinetics to folate 
receptors in the body. During the recent years, it has become increasingly clear 
that binding affinity alone may not always be a suitable description of biological 
activity. Since the equilibrium dissociation constant (KD) are calculated by the 
quotient of kd/ka the same affinity value can result from different combinations of 
association and dissociation rates. In cases where the association or the 
dissociation rate dictates biological activity, affinity alone may be a directly 
misleading measure of activity (reviewed by Andersson & Hämäläinen, 2006). 
Rich et al (2002) found that estrogen receptor agonists had 100-fold higher   24
association rates than antagonists, irrespective of dissociation rate.  The results in 
this study show that folic acid has almost 10-fold higher association rate than [6S]-
5-CH3H4folate and almost 50-fold slower dissociation rate. The physiological 
importance of the differences in rate constants for folic acid compared to those of 
[6S]-5-CH3H4folate is not known. The fact that molecules that act on the same 
receptor but with opposite function, i.e. agonist and antagonists, have been 
discriminated by kinetics and not by affinity supports the importance of binding 
kinetics.  
 
The achieved response in competitive binding methods, e.g. RPBA, depends on 
folate derivative used as a standard and on the folate derivatives in the sample. 
Simplified, the differences in response depend on difference in affinity between 
FBP and the different folate derivatives. Yet, strictly speaking, the differences 
depend on differences in binding kinetics because the assay does not reach 
equilibrium during the incubation. To reach equilibrium for interactions with such 
slow dissociation rate as folic acid and [6R]-5-CH3H4folate will take days at the 
low concentrations used. 
 
 
IV. Letter to the editor (Paper IV) 
Christensen et al. (2006) published an article on the interaction between folic acid 
and bovine FBP using the stopped-flow technique. They interpreted their binding 
data and concluded the interaction to consist of at least three steps at pH 7.4 and 
two steps at pH 5.0 and rejected a simple one-step binding model (A + B = AB). 
These results are contradictory to results from Paper III because we were able to 
fit our kinetic data for the interaction between different folate derivatives and FBP 
to a simple one-step binding model and no improvement in curve fit was seen 
when using more complex models. It was, therefore, suggested that the complex 
binding models described by Christensen et al. were due to rate limiting parallel 
reactions resulting from the dissociation of pre-formed FBP aggregates caused by 
the high protein concentration used in the experiment. The binding between folate 
and monomeric FBP is most likely a simple 1:1 interaction mechanism. 
 
 
V. The effect of different folate forms on denaturation of bovine 
folate-binding protein (Paper V) 
The influence of different folate derivatives on the denaturation temperature of 
FBP was investigated using DSC. The effect of heat treatment, i.e. pasteurization 
and UHT treatment, on FBP binding to folate was studied using the surface 
plasmon resonance technique. The folate derivatives studied were (6S)5-HCO-
H4folate, (6S)5-CH3-H4folate and folic acid.  
 
The results show that different folate forms affect heat denaturation of FBP 
differently and this effect is probably related to the affinity of FBP to the different 
folate forms. Apo-FBP undergoes an endothermic transition with a maximum at 
60.5ºC. After ligand binding, the maximum of the denaturation shifts with a 
transition maximum at 72.4ºC for (6S)5-HCO-H4folate and 78.7ºC for (6S)5-CH3-  25 
H4folate. The highest temperature shift was observed for folic acid with maximum 
transition temperature at 83.7ºC. These results relate well to the affinity data 
published in Paper III; the order of affinity for FBP was folic acid > (6R)5-CH3-
H4folate > (6S)-H4folate > (6S)5-CH3-H4folate > (6S)5-HCO-H4folate. 
Wasylewski (2000) found that the apo-form of the structurally related Riboflavin-
binding protein (RfBP) undergoes endothermic transition with a maximum at 
60.8ºC. The endothermic transition maximum increased after riboflavin binding to 
72.8°C. These data correspond well with our data. Slightly different results were 
obtained by Sigurskjold et al (1997) for FBP. They found that thermal unfolding 
of FBP occurs at 48.4ºC, and they measured a denaturation temperature of 72ºC 
for holo-FBP. However, the publication does not mention which folate derivative 
was studied. 
  
The results obtained by SPR assay showed that heat treatment close to 
pasteurization temperature did not eliminate the binding capacity of FBP 
regardless of folate form bound, but higher temperature of UHT treatment did. 
Based on these results, UHT or other high temperature treatments of foods 
containing FBP will most likely increase bioavailability of folic acid and mildly 
heat treatment, e.g. pasteurization, will reduce bioavailability of folic acid. These 
effects should be taken into account when considering the folate intake by humans 
because the bioavailability of folate strongly depends on its interaction with the 
food matrix. Today most infant formulas are gently heat processed and fortified 
with folic acid; the bioavailability will probably be reduced because of active FBP 
and should be considered.   
  
During SPR analysis of FBP an increase in mass on the sensor surface after heat 
treatment close to pasteurization temperature was observed. The increase was 
probably due to heat induced aggregation of FBP. This finding is in accordance 
with the observation of Gregory (1982). He described a heat induced increase in 
molecular mass of FBP using gel filtration analysis.  
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Methodological considerations 
The main focus of this thesis has been the use of an SPR-based biosensor to detect 
and characterise FBP. The SPR-based biosensors have enormous, almost 
unlimited possibilities, because they measure the interaction between nearly any 
molecules in real time, without any labelling. However, there are some concerns 
that the surface of the biosensor might affect binding interaction. Techniques such 
as ELISA, filter-binding assays and some RIA methods also rely on a surface and 
have been used for years without being questioned. Many interaction of 
importance in biology occur on the interface of a surface, e.g. cell surface, and 
from that point of view it is an advantage to measure interactions at a surface. The 
main problem is probably the user and not the instrument itself. Pitfalls, when 
using the instrument both for concentration and kinetic analysis include sample 
heterogeneity, aggregation and non-specific binding. Being aware of these issues 
is important especially because the instruments are so easily operated. When 
reading the annual survey of the optical biosensor literature by Rich & Myszka 
(2000-2006) it becomes clear that much of the published biosensor data is of low 
quality and this is because of the lack of sufficient knowledge of the instrument by 
the users. These instruments require dedicated, well-trained and knowledgeable 
operators to get most out of them. At the beginning of my PhD work I did not 
have this knowledge. However, during the following years I have become aware 
of at least some of the possible problems that might occur when working with SPR 
technology. In this case the most important complication was protein aggregation. 
 
Aggregation 
When working with FBP experiencing aggregation is unavoidable. Much of what 
have been published about FBP is directly or indirectly related to this 
phenomenon. Contradictory results both for equilibrium constants and deviations 
from 1:1 interaction model are in my opinion caused by aggregation. As 
mentioned earlier,  it is important that the biosensor user is aware of possible 
pitfalls. However, evidently, as discussed in Paper IV, it is also possible to fall 
into the same pitfalls using other techniques and draw conclusions that a complex 
binding profile is a result of some biologically interesting phenomena.  
 
There are no data in this thesis that show the exact nature of FBP aggregates. 
However, when working with the SPR instrument differences in the behavior of 
the aggregates, depending on whether the ligand was present or not, were 
observed. Moreover, there were differences between the “native-” and heat-
induced aggregates, because the heat-induced aggregates appeared to be more 
stable and did not dissociate when diluting the samples. It is therefore likely that 
the divergent behavior of the heat-induced aggregates seen during analysis by 
SPR-biosensor (Paper V) is a non-specific coagulation of partially denatured 
polypeptides. The nature of the aggregation of the native protein is probably due 
to more specific intermolecular interactions. It is known that presence of ligand 
increases the aggregation tendency and that holo-FBP forms hydrophilic water-
soluble polymers, whereas apo-FBP aggregates have a hydrophobic character 
(Holm, Hansen & Hoier-Madsen, 2001). The work in this thesis has further shown   27 
that unliganded FBP and liganded FBP aggregates with each other (Paper V). 
Unpublished data indicate that there is a conformational change as suggested by 
Hansen & Holm (2001) but not during the folate-FBP interaction; instead, the 
conformational change happens when holo-FBP aggregates. This is in agreement 
with circular dichroism results of Kaarsholm et al (1993). I therefore suggest that 
the apo-apo interaction are simple 1:1 interactions (A + B = AB), whereas the 
holo-holo interaction is followed by a second conformational changing step. 
 
During the work described in Paper III I realized the importance of FBP 
aggregation. Consequently, no consideration for this phenomenon was taken in the 
two first studies. In Paper I an SPR biosensor assay that detected FBP and 
differentiated between the apo and holo-form of the protein was developed. The 
SPR biosensor assay showed good compliance with an existing ELISA method 
and a high repeatability. Later, when working with heat-treated FBP in milk 
(Paper V), it was seen that changes due to heat treatment influenced the response 
at the sensor surface. It was observed (unpublished results) that freeze storage of 
the milk samples for longer periods, i.e. 6 months or more, also increased the 
response especially for the measured apo-FBP. The fact that the response 
increased more for apo-FBP is probably due to the lack of pre-treatments that 
dissociate the aggregates. To facilitate measurements of the total FBP content in 
milk, endogenous folate is removed by a combination of low pH to dissociate the 
FBP-folate complex followed by a membrane molecular weight cut-off filtration. 
It is possible that the aggregates formed during freeze storage dissociate due to the 
low pH. The samples used in the study described in Paper II were stored for only 
a few weeks at -80ºC before analysis, which most likely did not cause aggregation. 
In addition, differences in FBP level between milk samples and therefore 
statistical conclusions are valid because all the samples were stored and treated in 
a similar way.  
 
Heterogeneity 
A common FBP source used in purification of bovine FBP is whey powder 
concentrate (Svendsen et al., 1979; Treloar, Grieve & Nixon 2000). This is also 
the source used in the present work. Because whey protein concentrate have been 
exposed for different heat treatments, the conformational purity of FBP cannot be 
guaranteed. An important issue when working with SPR biosensors is to secure 
high quality samples to avoid problems with heterogeneity and aggregation. As I 
realized later, raw milk as a FBP source would have been a better choice. However 
I need to emphasize that there were no signs of heterogeneity seen in the curve fit 
for the interaction between folate and FBP, as shown in Paper V. Consequently, 
FBP that is not irreversible destroyed during heat treatment does not change its 
binding properties to the ligand. Heterogeneity was, on the other hand, observed in 
the dissociation curves for the FBP-FBP interaction (not shown), probably caused 
by terminally exposed amino acids. 
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Non-specific binding 
Non-specific binding could either be caused by binding of analyte, in this case 
FBP to non-specific sites on the surface, or by binding of non-analyte molecules, 
in this case whey. FBP itself showed no non-specific binding to the sensor surface 
when diluted in HBS-EP buffer, however, whey did. To counteract non-specific 
binding from whey, a phosphate buffer with a high salt concentration (0.5 M) was 
introduced before the change in response due to bound FBP was measured. This 
successfully reduced the effect of non-specific binding from the whey.  
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Conclusions and future research  
This thesis describes an SPR-based method for detection of FBP in cow milk. The 
assay differentiates between the unliganded (apo) and the total FBP content and 
provides a useful tool for analysis of FBP concentration as well as kinetics of FBP 
interactions. The method is reliable to use for fresh milk and samples that have 
been freeze stored for a relatively short period; however, it needs to be further 
evaluated with respect to FBP aggregation, particularly aggregation induced by 
long term freeze storage. It cannot be used for milk samples exposed to heat at 
close denaturation temperatures because of the disproportional increase in 
response, which is also most likely due to aggregation. 
 
Screening of Swedish dairy cows for FBP concentration in milk shows 
considerable variation between individuals. The most influential factor affecting 
FBP levels is the stage of lactation; the levels are high at the beginning of lactation 
and decrease considerably as lactation progresses. The ratio between FBP and its 
apo-form is, however, fairly constant and approx. 50% of the FBP remains 
unliganded. The total protein content is positively related to the amount of apo-
FBP and negatively related to the holo-form. Breed does not seem to affect FBP 
levels.  
 
The analysis of the binding kinetics of interactions between FBP and different 
folate derivatives demonstrates that the interaction is a simple 1:1 binding (A + B 
= AB). The rate constants differ between the derivatives and the association rate is 
almost 10-fold faster for folic acid than any of the other derivative tested. Folic 
acid and (6R)5-CH3-H4folate, the two folate derivatives that do not exist in nature, 
have the highest affinity for FBP. The order of affinity for FBP is folic acid > 
(6R)5-CH3-H4folate > (6S)-H4folate > (6S)5-CH3-H4folate > (6S)5-HCO-H4folate. 
The impact of the differences in rate constants for the different folate derivatives 
needs to be further investigated with nutritional studies.  
 
The shift in denaturation temperature due to ligand binding corresponded well 
with the affinity data; the higher affinity of the ligand to FBP, the higher 
denaturation temperature of the FBP-ligand complex. Further, all reduced folate 
derivative tested increases the denaturation temperature of FBP to a temperature 
close to pasteurization temperature. Pasteurization temperatures do not eliminate 
the binding capacity of FBP, whereas UHT treatment does. Due to the high 
proportion of unliganded FBP in fresh and pasteurized milk and the fact that folic 
acid forms strong complex with FBP, mildly heat-treated cow milk is not a good 
vehicle for folic acid fortification. 
 
This thesis have shown that SPR-technology provide new possibilities to study 
binding characteristics of bioactive substances in foods, which, in combination 
with nutrition studies, would give new knowledge in the field of food science and 
nutrition. Further, SPR technology could be useful for studying protein 
aggregation and could provide new useful information about interactions in food 
systems. Particularly, because proteins are widely used in food industry as 
texturisers and this is based on the ability of proteins to aggregate.     30
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